
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
David Diamond, PhD discusses Forgotten Baby Syndrome and its impact on vehicular heat stroke fatalities.
David Diamond, PhD discusses Forgotten Baby Syndrome and its impact on vehicular heat stroke fatalities.






